This journal uses double-blind peer reviews, meaning both reviewer and author identities are concealed from reviewers throughout the review process, and vice versa. Every manuscript submitted should be peer-reviewed by two or more relevant experts, (3 most relevant investigators available for review of the original article and case report) as regards the appropriateness of publishing. Its publishing should be decided on the basis of the deliberation and its author may be advised to revise or complement its content. Advised to revise its content, the author should revise the manuscript and submit the revised manuscript along with his/her answer on the processing of the items pointed out by judges in a file form.
Ji Yoon Yu, M.D., Tae Hwan Kim, M.D., Ye Ji Kim, M.D., Hyun Mi Kang, M.D. Ph.D., In Hyuk Yoo, M.D. Ph.D., Jung Woo Rhim, M.D., Ph.D., Soo Young Lee, M.D., Ph.D., Dae Chul Jeong, M.D., Ph.D.
J Rheum Dis 2024;31: 49-53Hyeji Jeon, M.D., Bo Da Nam, M.D., Chong-Hyeon Yoon, M.D, Ph.D., Hyun-Sook Kim, M.D, Ph.D.
J Rheum Dis 2024;31: 3-14Young Ho Lee, M.D., Ph.D, Gwan Gyu Song, M.D., Ph.D.
J Rheum Dis 2023;30: 116-125Se Hee Kim, M.D., Sang-Hoon Lee, M.D., Ph.D.
J Rheum Dis 2023;30: 220-233+82-2-794-2631